HYOSCYAMINE

SynDRA canonical compound SYN0025027 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	CHRM1 \| CHRM2 \| CHRM3 \| CHRM4
Mechanism of action	acetylcholine receptor antagonist
Indication	acute abdominal visceral spasm \| allergic rhinitis \| enterocolitis \| interstitial cystitis (IC) \| irritable bowel syndrome \| peptic ulcer disease (PUD) \| tremors \| ulcerative colitis
Disease area	allergy \| gastroenterology \| neurology/psychiatry \| urology

All known targets

hyoscyamine hydrobromide
(-)-Atropine
(-)-Hyoscyamine
L-Hyoscyamin
L-Hyoscyamine
l-Atropine
hyoscyamine sulfate
(-)-atropine
(-)-hyoscyamine
(s)-(-)-hyoscyamine
Atropine, (s)-
Bellafoline
Cystospaz
Daturine
Duboisine
Hyoscyaminum
L-hyoscyamine
NSC-757064
L-tropic acid ester with tropine
L-Tropine tropate
(S)-Atropine
(S)-(-)-Hyoscyamine
Hyoscyamine (L)
UNII-PX44XO846X
Tropine, (-)-tropate
Levbid
PX44XO846X
Levsinex SR
CHEBI:17486
Hyoscyamine, l-
[3(S)-endo]-alpha-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[321]oct-3-yl ester
(2S)-(1R,5S)-8-Methyl-8-azabicyclo[321]octan-3-yl 3-hydroxy-2-phenylpropanoate
(1R,5S)-8-METHYL-8-AZABICYCLO[321]OCT-3-YL (2R)-3-HYDROXY-2-PHENYLPROPANOATE
Hyocyamine
Levsin
ENDO-ATROPINE
[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] (2S)-3-hydroxy-2-phenylpropanoate
1-Hyoscyamine